You searched for "endothelial"
Management of DMO and PDR in 2019
An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...My ophthalmology taster week experience at Whipps Cross Eye Treatment Centre
Deciding to explore ophthalmology Having read about ophthalmology, I have always found myself fascinated about what a career in ophthalmology entails. I have often wondered what ophthalmologists actually do, as we as medical students did not have a lot of...A life outside ophthalmology
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...Conference Preview: UKISCRS, UKISOP and YOP 2025
London’s calling, and we will be rejoining the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS), the Young Ophthalmologists Programme (YOP), and United Kingdom & Ireland Society of Ophthalmic Practitioners (UKISOP) between 12–14 November. The former will...Troubleshooting in LASIK
Contemporary laser in situ keratomileusis (LASIK) is safe and effective. It remains the dominant intervention in routine refractive surgery for a good reason: predictable results, rapid visual recovery, and relatively simple strategies for revision treatment. Over 95% of patients are...Neovascular AMD: fresh recommendations underline standards of best practice
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...
Retinoblastoma chemotherapeutic drugs and their toxic effects on RPE cells
There is reported clinical evidence of retinal pigment epithelium (RPE) alterations after intra-arterial (IAC) and intravitreal chemotherapy (IViC) of retinoblastoma. The purpose of this study was to investigate the cellular toxic effects of melphalan, topotecan and carboplatin on the RPE...
OCTA and pigment epithelium detachments
Yannuzzi et al. report on their study aiming to evaluate the ability of optical coherence tomography angiography (OCTA) to differentiate vascularised from nonvascularised pigment epithelium detachments (PEDs) using conventional imaging techniques, including fundus fluorescein angiography (FFA) and indocyanine green (ICG),...
